This inventor holds 2 USPTO granted patents. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1996-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- New York, NY (US) (1996)
- Clinton, CT (US) (1997)
Company Filing History:
Years Active: 1996-1997
Title: Innovations of Lawrence B Snyder in Cancer Research
Introduction
Lawrence B Snyder is a prominent inventor based in New York, NY, known for his significant contributions to cancer research. He has been instrumental in developing innovative methods for synthesizing important compounds used in cancer treatment. With a total of 2 patents, Snyder's work has had a profound impact on the field of oncology.
Latest Patents
Snyder's latest patents include groundbreaking work on the total synthesis of taxol and its analogues. This invention provides three basic routes for the total synthesis of taxol, along with the intermediates produced in these processes. Additionally, he has developed camptothecin analogues and methods of preparation thereof. These substituted analogues possess cytotoxic activity towards cancer cells, offering new avenues for cancer treatment.
Career Highlights
Snyder is affiliated with the Sloan-Kettering Institute for Cancer Research, where he continues to advance the field of cancer therapeutics. His research focuses on creating effective treatments that can improve patient outcomes. His dedication to innovation in cancer research has established him as a key figure in the scientific community.
Collaborations
Throughout his career, Snyder has collaborated with notable scientists such as Samuel J Danishefsky and John J Masters. These collaborations have further enriched his research and contributed to the development of new cancer therapies.
Conclusion
Lawrence B Snyder's innovative work in cancer research exemplifies the importance of scientific advancement in the fight against cancer. His patents and collaborations highlight his commitment to improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
